Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mesenchymal stromal cell therapy for coronavirus disease 2019: which? when? and how much?
Pradnya Shahani, Indrani Datta
Cytotherapy (2021) Vol. 23, Iss. 10, pp. 861-873
Open Access | Times Cited: 11

Showing 11 citing articles:

Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial
Morteza Zarrabi, Mohammad Amin Shahrbaf, Masoumeh Nouri, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 41
Safety of DW-MSC infusion in patients with low clinical risk COVID-19 infection: a randomized, double-blind, placebo-controlled trial
Muhammad Karyana, Irawaty Djaharuddin, Lutfah Rif’ati, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 31
Updated Living Systematic Review and Meta-analysis of Controlled Trials of Mesenchymal Stromal Cells to Treat COVID-19: A Framework for Accelerated Synthesis of Trial Evidence for Rapid Approval—FASTER Approval
Aidan M. Kirkham, Adrian Bailey, Madeline Monaghan, et al.
Stem Cells Translational Medicine (2022) Vol. 11, Iss. 7, pp. 675-687
Open Access | Times Cited: 28
Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects: Update from 2015 review
Leah A. Marquez‐Curtis, Janet A.W. Elliott
Cryobiology (2024) Vol. 115, pp. 104856-104856
Open Access | Times Cited: 3
Feasibility Study of Cord Tissue Derived Mesenchymal Stromal Cells in COVID-19-Related Acute Respiratory Distress Syndrome
Beth H. Shaz, Bryan Kraft, Jesse D. Troy, et al.
Stem Cells Translational Medicine (2023) Vol. 12, Iss. 4, pp. 185-193
Open Access | Times Cited: 4
Clinical Trials of Mesenchymal Stem Cells for the Treatment of COVID 19
Elham Zendedel, Lobat Tayebi, Mohammad Reza Nikbakht, et al.
Current Stem Cell Research & Therapy (2023) Vol. 19, Iss. 8, pp. 1055-1071
Closed Access | Times Cited: 3
Scale-Up of Academic Mesenchymal Stromal Cell Production
Caroline Laroye, Mélanie Gauthier, Jessica Morello, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4414-4414
Open Access | Times Cited: 2
Immunomodulatory effect of IFN-γ licensed adipose-mesenchymal stromal cells in an in vitro model of inflammation generated by SARS-CoV-2 antigens
Elizabete Cristina Iseke Bispo, Enrique R. Argañaraz, Francisco de Assis Rocha Neves, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Overview of Cellular Therapy
Camelia Iancu‐Rubin, Rona Singer Weinberg
Elsevier eBooks (2024), pp. 417-422
Closed Access
The role of intensive care nurses in cellular treatments during the COVID‐19 pandemic
Figen Çalışkan, İrem Özdemir, Ayten Zeydan, et al.
Nursing in Critical Care (2023)
Closed Access | Times Cited: 1
Treatment of COVID-19 with MSCs: how does it work?
Armand Keating
Science China Life Sciences (2021) Vol. 65, Iss. 4, pp. 849-850
Open Access
Page 1

Scroll to top